POLERA', NICOLETTA
 Distribuzione geografica
Continente #
NA - Nord America 248
EU - Europa 235
AS - Asia 136
SA - Sud America 25
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 646
Nazione #
US - Stati Uniti d'America 242
IT - Italia 157
SG - Singapore 72
CN - Cina 30
DE - Germania 28
BR - Brasile 22
GB - Regno Unito 19
IN - India 18
FI - Finlandia 13
HK - Hong Kong 8
CA - Canada 6
FR - Francia 5
ES - Italia 3
NL - Olanda 3
SE - Svezia 3
VN - Vietnam 3
RU - Federazione Russa 2
AT - Austria 1
BD - Bangladesh 1
EC - Ecuador 1
ET - Etiopia 1
EU - Europa 1
IQ - Iraq 1
JP - Giappone 1
LB - Libano 1
PK - Pakistan 1
PL - Polonia 1
PY - Paraguay 1
VE - Venezuela 1
Totale 646
Città #
Singapore 40
Dallas 38
Munich 23
Ashburn 22
Chandler 22
Santa Clara 19
Chicago 15
Bengaluru 14
Hefei 14
London 14
Parma 13
Turku 10
Milan 9
Hong Kong 8
Naples 8
New York 8
Santo Stefano di Rogliano 8
Beijing 7
Los Angeles 7
Rome 7
Catanzaro 6
Melito di Porto Salvo 6
San Nicola Manfredi 6
Afragola 5
Catania 5
Brescia 4
Brooklyn 4
Lawrence 4
Princeton 4
Acquaviva delle Fonti 3
Castrovillari 3
Helsinki 3
Montreal 3
Phoenix 3
San Antonio 3
Agrigento 2
Bologna 2
Campina Grande 2
Campobello di Licata 2
Chennai 2
Denver 2
Ercolano 2
Frankfurt am Main 2
Grottaglie 2
Paris 2
Redmond 2
Romainville 2
Serra San Bruno 2
Sorrento 2
Vallefiorita 2
Washington 2
Ahmedabad 1
Arnhem 1
Atlanta 1
Aversa 1
Bagé 1
Bari 1
Beirut 1
Belovo 1
Bisignano 1
Bismarck 1
Biên Hòa 1
Boardman 1
Boston 1
Buffalo 1
Campina Verde 1
Caracas 1
Columbus 1
Delta Junction 1
Des Moines 1
Desert Hot Springs 1
Dhaka 1
Extrema 1
Flint 1
Glasgow 1
Hanoi 1
Hanover 1
Hyderabad 1
Iguape 1
Indaiatuba 1
Ipswich 1
Itapetinga 1
Itapuranga 1
Jaraguá do Sul 1
Juiz de Fora 1
Kansas City 1
King City 1
La Paloma del Espíritu Santo 1
Leawood 1
Lithonia 1
Livorno 1
Madrid 1
Manchester 1
Mangaratiba 1
Mantachie 1
Melito di Napoli 1
Mogi Mirim 1
Nanuque 1
Natal 1
North York 1
Totale 449
Nome #
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 113
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 66
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 61
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 55
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 54
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 49
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 46
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 45
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 42
The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives 39
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 37
An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma 35
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure-based virtual screening 24
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma 22
Totale 688
Categoria #
all - tutte 5.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 1 4 4 2 0 0
2021/202223 0 0 0 2 4 1 9 1 4 0 2 0
2022/2023132 14 9 2 4 12 10 5 5 15 20 36 0
2023/2024100 21 14 10 7 6 28 5 3 0 3 0 3
2024/2025250 23 2 4 5 21 37 16 23 13 2 33 71
2025/2026170 28 48 43 36 15 0 0 0 0 0 0 0
Totale 688